Study on the biological characteristics of ILC cells in asthma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048748

Enrollment

Unknown

Registered

2021-07-15

Start date

2021-07-15

Completion date

Unknown

Last updated

2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Test group:NO

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Healthy person1 1. Age>=18 years old. 2. No history of immune and allergic diseases. 3. No use of corticosteroids or other immunosuppressive drugs in the past 4 weeks. 4. Volunteered to participate in the study and signed the informed consent. Asthma 1.Compliance with the diagnostic criteria of bronchial asthma prevention and treatment guideline 2020; 2.Volunteered to participate in the study and signed the informed consent; 3.Age>=18 years old, gender unlimited; 4.No serious heart, lung, brain, liver, kidney, blood system diseases; 5.Life expectancy is not less than 1 year.

Exclusion criteria

Exclusion criteria: 1. Women who plan to become pregnant/lactating/pregnant; 2.Unconscious or unable to cooperate; 3. Suffer from immune disease.

Design outcomes

Primary

Measure	Time frame
Proportion of ILCs;Inflammatory cytokines in blood;eosinophil count in induced sputum;Lung function;	—

Countries

China

Contacts

Public ContactLiu Jing

the Fifth affiliated Hospital of Sun Yat-Sen University

liujing25@sysu.edu.cn+86 13844021812

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026